$148.00/50µL $248.00/100µL
50 µL | $148.00 |
100 µL | $248.00 |
Product name: | ITGA2B (light chain form 1, Cleaved-Gln891) rabbit pAb |
Reactivity: | Human;Rat;Mouse; |
Alternative Names: | Integrin alpha-IIb (GPalpha IIb;GPIIb;Platelet membrane glycoprotein IIb;CD antigen CD41) [Cleaved into: Integrin alpha-IIb heavy chain; Integrin alpha-IIb light chain, form 1; Integrin alpha-IIb light chain, form 2] |
Source: | Rabbit |
Dilutions: | WB 1:500-2000;IHC-p 1:50-300 |
Immunogen: | Synthesized peptide derived from human ITGA2B (light chain form 1, Cleaved-Gln891) |
Storage: | -20°C/1 year |
Clonality: | Polyclonal |
Isotype: | IgG |
Concentration: | 1 mg/ml |
Observed Band: | 16 110kD |
GeneID: | 3674 |
Human Swiss-Prot No: | P08514 |
Cellular localization: | Membrane; Single-pass type I membrane protein. |
Background: | This gene encodes a member of the integrin alpha chain family of proteins. The encoded preproprotein is proteolytically processed to generate light and heavy chains that associate through disulfide linkages to form a subunit of the alpha-IIb/beta-3 integrin cell adhesion receptor. This receptor plays a crucial role in the blood coagulation system, by mediating platelet aggregation. Mutations in this gene are associated with platelet-type bleeding disorders, which are characterized by a failure of platelet aggregation, including Glanzmann thrombasthenia. [provided by RefSeq, Jan 2016], |